Su1593 LIVER AND NON-LIVER OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) VERSUS MASLD WITH INCREASED ALCOHOL USE (METALD) STRATIFIED BY PRESENCE OF VIRAL HEPATITIS: A STUDY OF 850,156 REAL-WORLD PATIENTS IN THE U.S.